• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Human characteristic mechanism of enzyme induction and the prediction

Research Project

Project/Area Number 13470510
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field 応用薬理学・医療系薬学
Research InstitutionTohoku University

Principal Investigator

YAMAZOE Yasushi  Tohoku Univ., Grad. Sch. of Pharm. Sci., Prof., 大学院・薬学研究科, 教授 (00112699)

Co-Investigator(Kenkyū-buntansha) FURUKAWA Masayuki  Otsuka Pharmaceutical Co., Ltd., Res., 研究員
MIYATA Masaaki  Tohoku Univ., Grad. Sch. of Pharm. Sci., assist., 大学院・薬学研究科, 助手 (90239418)
NAGATA Kiyoshi  Tohoku Univ., Grad. Sch. of Pharm. Sci., Ass. Prof., 大学院・薬学研究科, 助教授 (80189133)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥14,300,000 (Direct Cost: ¥14,300,000)
Fiscal Year 2002: ¥5,300,000 (Direct Cost: ¥5,300,000)
Fiscal Year 2001: ¥9,000,000 (Direct Cost: ¥9,000,000)
Keywordsenzyme induction / stable expression / CYP3A4 / human drug metabolism / PXR / 誘導評価系 / 安定発現株 / レポーターアッセイ / スクリーニング / in vivo / CYP3A / cyt.P450 / Induction / PXR
Research Abstract

As an estimation tool for human CYP3A4 induction, we have succeeded to make an adenovirus vecter system including CYP3A4 promoter and enhancer regions. The vecter was used to obtain the stably active clones in HepG2 cells. Among the clones selected, couple clones responded to typical chemical induces and showed high luciferase reporter activities. These clones are found to be candidates as effective tools for the quantitative prediction of inducing potential for human CYP3A4. We are currently evaluating the clones for the practical tools.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] M.Furukawa: "Adenovirus vector-mediated reporter system for in vivo analyses of human CYP3A4 gene activation"J. Biochem.. 131. 71-78 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Ogino: "Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells"Drug Metabol. Pharmacokin.. 17. 42-46 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nagata: "Genetic polymorphism of human cytochrome P450 involved in drug metabolism"Drug Metabol. Pharmacokin.. 17. 167-189 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Furukawa: "Adenovirus vector-mediated reporter system for in vivo analyses of human CYP3A4 gene activation"J.Biochem.. 131. 71-78 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] M.Ogino: "Selective suppressions of human CYP3A forms, CYP3A5 and CYP3A7, by troglitazone in HepG2 cells"Drug Metabol. Pharmacokin.. 17. 42-46 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] K.Nagata: "Genetic polymorphism of human cytochrome P450 involved in drug metabolism"Drug Metabol. Pharmacokin.. 17. 167-189 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] S.Matsumoto: "Involvement of CYP2J2 on the intestinal first-pass metabolism of antihistamine drug, astemizole"Drug Metab. Dispos.. 30. 1240-1245 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Ogino: "Selective suppression of human CYP3A form, CYP3A7, by troglitazone in HepG2 cells"Drug Metab. Pharmacokin.. 17. 42-46 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Shimada: "A hydroxysteroid sulfotransferase, St2b2, in a skin cholesterol sulfotransferase in mice"J. Biochem.. 131. 167-169 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] W.Homma: "Phenol sulfotransferase, ST1A3, as the main enzyme catalyzing sulfation of triglitazone in human liver"Drug Metab. Dispos.. 30. 944-949 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Furukawa: "Adenovirus vector-mediated reporter system for in vivo analysis of the human CYP3A4 gene activation"J. Biochem.. 131. 71-78 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] M.Furukawa: "Adenovirus vector-mediated reporter system for in vivo analyses of human CYP3A4 gene activation"J. Biochem.. 131. 71-78 (2002)

    • Related Report
      2001 Annual Research Report
  • [Publications] M.Ogino: "Selective suppressions of human CYP3A form, CYP3A5 and CYP3A7, by troglitazane in HepG2 cells"Drug Metabol. Pharmacokin.. 17. 42-46 (2002)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi